|
US - Bristol-Myers Squibb Co planned to launch a challenging offer to acquire the remaining ##% interest, or ##.### mil common shares plus options, which it did not already own, in ImClone Systems Inc (IC), a biotechnology company, for…
|
| Credit & Investment Research |
|
|